Skye Bioscience, Inc. (SKYE)
USD 3.01
(-7.38%)
USD 3.01
(-7.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 124.25 Thousand | 114.99 Thousand | 34.13 Thousand | 1872.00 | 1462.00 | 1544.00 |
| Gross Profit | -124.25 Thousand | -114.99 Thousand | -34.13 Thousand | -1872.00 | -1462.00 | -1544.00 |
| Operating Expenses | 13.54 Million | 12.1 Million | 7.84 Million | 6.28 Million | 6.63 Million | 4.69 Million |
| Selling, General and Administrative Expenses | 7.72 Million | 6.09 Million | 4.91 Million | 4.34 Million | 4.39 Million | 4.36 Million |
| Research and Development Expenses | 5.81 Million | 6.01 Million | 2.93 Million | 1.94 Million | 2.23 Million | 329.96 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 13.67 Million | 12.1 Million | 7.84 Million | 6.28 Million | 6.63 Million | 4.69 Million |
| Operating Income | -13.67 Million | -18.31 Million | -7.84 Million | -6.28 Million | -6.63 Million | -4.69 Million |
| Interest Expense | 906.27 Thousand | 665.13 Thousand | 767.51 Thousand | 706.38 Thousand | 987.8 Thousand | 94.76 Thousand |
| Income Tax Expense | 3600.00 | 6741.00 | 2100.00 | 1600.00 | 1600.00 | 1642.00 |
| Earnings before Tax | -37.64 Million | -19.47 Million | -8.52 Million | -6.55 Million | 1.05 Million | -19.19 Million |
| Net Income | -37.64 Million | -19.48 Million | -8.52 Million | -6.56 Million | 1.05 Million | -19.19 Million |
| Earnings Per Share Basic | -5.37 | -9.82 | -5.24 | -6.39 | 1.98 | -36.51 |
| Earnings Per Share Diluted | -5.37 | -9.82 | -5.15 | -6.39 | 1.98 | -36.51 |
| Weighted Average Shares Outstanding | 7 Million | 1.98 Million | 1.62 Million | 1.02 Million | 532 Thousand | 525.78 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7 Million | 1.98 Million | 1.65 Million | 1.02 Million | 532 Thousand | 525.78 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -13.54 Million | -12.09 Million | -7.81 Million | -6.28 Million | 2.04 Million | -4.69 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 191.76 Thousand | - | - |
| Cost of Revenue | - | - | 124.25 Thousand | 28.37 Thousand | 28.78 Thousand | 33.91 Thousand |
| Gross Profit | - | - | -124.25 Thousand | 163.38 Thousand | -28.78 Thousand | -33.91 Thousand |
| Operating Expenses | 8.4 Million | 6.15 Million | 13.54 Million | 4.05 Million | 3.49 Million | 2.99 Million |
| Selling, General and Administrative Expenses | 4.32 Million | 4.2 Million | - | 2.46 Million | 2.23 Million | 1.2 Million |
| Research and Development Expenses | 4.07 Million | 1.94 Million | - | 1.59 Million | 1.25 Million | 1.78 Million |
| Other Expenses | -359.00 | - | 21.06 Million | 1.02 Million | 21.21 Million | 209.43 Thousand |
| Cost and Expenses | 8.4 Million | 6.15 Million | 13.67 Million | 4.08 Million | 3.49 Million | 2.99 Million |
| Operating Income | -8.4 Million | -6.15 Million | -13.67 Million | -4.08 Million | -24.7 Million | -2.84 Million |
| Interest Expense | 450.05 Thousand | 436.93 Thousand | 906.27 Thousand | 430.13 Thousand | 291.81 Thousand | 186.42 Thousand |
| Income Tax Expense | 8071.00 | 2000.00 | 3600.00 | -982 Thousand | 291.81 Thousand | 3600.00 |
| Earnings before Tax | -7.89 Million | -5.01 Million | -37.64 Million | -4.41 Million | -24.94 Million | -3.1 Million |
| Net Income | -7.9 Million | -5.01 Million | -37.64 Million | -4.41 Million | -24.94 Million | -3.11 Million |
| Earnings Per Share Basic | -0.20 | -0.18 | - | -0.36 | -3.17 | -0.80 |
| Earnings Per Share Diluted | -0.20 | -0.18 | - | -0.36 | -3.17 | -0.80 |
| Weighted Average Shares Outstanding | 38.66 Million | 27.99 Million | 7 Million | 12.34 Million | 7.88 Million | 3.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.66 Million | 27.99 Million | 7 Million | 12.34 Million | 7.88 Million | 3.88 Million |
| Gross Margin | - | - | - | 0.85 | - | - |
| EBIT Margin | - | - | - | -21.16 | - | - |
| Profit Margin | - | - | - | -23.05 | - | - |
| EBITDA | -7.41 Million | -5.69 Million | - | -4.05 Million | -3.42 Million | -2.95 Million |
| Earnings Before Tax Margin | - | - | - | -21.31 | - | - |
MCOA
SLHGF
CHHHF
034310
MPHYF
CLWT